OLD National Bancorp IN Cuts Stake in The Clorox Company (NYSE:CLX)

OLD National Bancorp IN lowered its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 24.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,874 shares of the company's stock after selling 3,131 shares during the period. OLD National Bancorp IN's holdings in Clorox were worth $1,609,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in CLX. Innealta Capital LLC acquired a new position in Clorox during the second quarter worth $30,000. Trifecta Capital Advisors LLC lifted its position in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after acquiring an additional 130 shares in the last quarter. GoalVest Advisory LLC acquired a new position in Clorox during the 1st quarter valued at about $31,000. First Foundation Advisors bought a new stake in Clorox during the 1st quarter worth approximately $31,000. Finally, Family Firm Inc. purchased a new stake in shares of Clorox in the second quarter worth approximately $31,000. Institutional investors own 78.53% of the company's stock.

Wall Street Analysts Forecast Growth

CLX has been the topic of several analyst reports. Wells Fargo & Company cut their target price on Clorox from $135.00 to $130.00 and set an "underweight" rating on the stock in a research report on Wednesday, July 10th. BNP Paribas raised shares of Clorox to a "strong sell" rating in a research report on Friday, September 6th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Clorox from $144.00 to $151.00 and gave the company a "hold" rating in a research note on Friday, August 2nd. Citigroup boosted their target price on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Finally, TD Cowen began coverage on Clorox in a research report on Tuesday, July 23rd. They set a "sell" rating and a $122.00 price target for the company. Six equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat, Clorox has an average rating of "Hold" and an average target price of $150.14.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company's stock, valued at $2,229,719.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.51% of the stock is currently owned by company insiders.

Clorox Stock Performance

Shares of NYSE CLX traded down $1.22 during midday trading on Tuesday, hitting $159.17. The company's stock had a trading volume of 871,701 shares, compared to its average volume of 1,226,728. The stock has a fifty day moving average price of $159.65 and a 200 day moving average price of $145.24. The firm has a market capitalization of $19.77 billion, a price-to-earnings ratio of 83.08, a P/E/G ratio of 3.19 and a beta of 0.41. The Clorox Company has a one year low of $114.68 and a one year high of $169.09. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The company had revenue of $1.90 billion during the quarter, compared to analysts' expectations of $1.97 billion. On average, research analysts forecast that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.07%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox's payout ratio is 252.85%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.